Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 24.4 Million Yuan Net Loss in First Half of 2022

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 24.4 million yuan in the first half of 2022, widening 243.6% year-on-year.

Meanwhile, the company posted 51.9 million yuan in revenue, down 32.8% year-on-year.

At the end of the reporting period, it had 373.4 million yuan in total assets and 332.3 million yuan in total liabilities, with a liability-to-asset ratio of 89%.